ARDSLEY ADVISORY PARTNERS LP - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 77 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.

Quarter-by-quarter ownership
ARDSLEY ADVISORY PARTNERS LP ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$10,210,000
+52.0%
510,000
+96.2%
1.38%
+36.2%
Q2 2018$6,716,000
+27.9%
260,000
+18.2%
1.01%
+28.3%
Q1 2018$5,251,000
-0.0%
220,000
+41.9%
0.79%
+23.4%
Q4 2017$5,253,000
+902.5%
155,000
+416.7%
0.64%
+1350.0%
Q2 2017$524,000
+99.2%
30,000
+100.0%
0.04%
+7.3%
Q1 2017$263,000
+3.5%
15,0000.0%0.04%
-2.4%
Q4 2016$254,000
+3.3%
15,0000.0%0.04%
+7.7%
Q3 2016$246,00015,0000.04%
Other shareholders

There were no reported owners of ADAMAS PHARMACEUTICALS INC in Q2 2017.

NameSharesValueWeighting ↓
View complete list of ADAMAS PHARMACEUTICALS INC shareholders